Rainbow International School
Education · South Korea · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Seoul, South KoreaWebsite
www.rischool.orgRevenue
$25.6 MillionIndustry
About Rainbow International School
Is Rainbow International School your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Rainbow International School launches new products
Click to see if Rainbow International School had a recent Job posting/layoffs
Check out if Rainbow International School is spiking on competitors!
Check if Rainbow International School has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Rainbow International School recently announced quarterly report
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Rainbow International School has new funding data
Rainbow International School, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Rainbow International School
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Rainbow International School is experiencing very low activity levels compared to other companies in the Education sector.
What does this means?
Rainbow International School is drawing exceptional interest within the Education industry, suggesting notable developments or strong market momentum, learn more about Rainbow International School.
Rainbow International School Tech Stack
A closer look at the technologies used by Rainbow International School
Top Education Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Rainbow International School
Rischool specializes in advanced laboratory research and development, focusing on SGLT2 inhibitors and their combination therapies for chronic limb-threatening ischemia patients. The company conducts extensive studies on various biological responses, including the effectiveness of treatments and vaccine development against diseases like malaria. Th... Read More